Objective:

To evaluate the association between hidradenitis suppurativa (HS) and cancer risk compared to the general population, focusing on specific cancer types.

Approach:

Key Findings:

• Patients with HS had 1.82 times the odds of developing cancer compared to the general population (unadjusted).
• Elevated risks were observed for head and neck cancers (2.41 times), respiratory cancers (1.81 times), hematologic malignancies (1.71 times), and gastrointestinal cancer (1.61 times).
• Increased odds for Hodgkin lymphoma (2.44 times) and non-Hodgkin lymphoma (1.15 times) were noted (unadjusted).
• Certain cancers, including bone, soft-tissue, breast, CNS, urogenital, and unspecified cancers, showed no increased risk.

Interpretation:

The findings suggest a multifactorial relationship between HS and cancer risk, potentially influenced by inflammation, comorbid conditions, and other factors.

Limitations:

• Limited adjustments for confounders such as smoking, obesity, and alcohol use.
• Inconsistent reporting of key variables like body mass index and ethnicity.
• Incomplete reporting of cancer subtypes and disease severity.

Conclusion:

Having HS is associated with an increased risk of cancer overall, including specific subtypes, compared to controls.

Sources:

• Dermatology and Therapy
Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.